Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R3MO
|
|||
Former ID |
DIB019455
|
|||
Drug Name |
PMID20684608C35
|
|||
Synonyms |
GTPL8209; BDBM50324574
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C27H33N5O3
|
|||
Canonical SMILES |
CN1CCC(CC1)COC2=C(C=CC(=C2)C3=CNN=C3)NC(=O)C4CC5=C(CN4)C=CC(=C5)OC
|
|||
InChI |
1S/C27H33N5O3/c1-32-9-7-18(8-10-32)17-35-26-13-19(22-15-29-30-16-22)4-6-24(26)31-27(33)25-12-21-11-23(34-2)5-3-20(21)14-28-25/h3-6,11,13,15-16,18,25,28H,7-10,12,14,17H2,1-2H3,(H,29,30)(H,31,33)/t25-/m1/s1
|
|||
InChIKey |
GFWDPXHTWJXOEI-RUZDIDTESA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors. J Med Chem. 2010 Aug 12;53(15):5727-37. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.